Masoud Bitaraf

@erfanamini So grateful ❤️

So proud of you!

@NimaSharifiMD @ASCO @dsui_miami_uro @SylvesterCancer Thank you Dr. Sharifi!

Congratulations ⁦@BitarafMasoudMD⁩ on your #GU26 presentation and your ⁦@ASCO⁩ merit award! ⁦@dsui_miami_uro⁩ ⁦@SylvesterCancer⁩

@Daniel_J_George Thank you Dr. George!

Congratulations, Masoud! Well done.

Glad to share that I have won the ⁦⁦@ConquerCancerFd⁩ Merit Award! Happy to see you on poster session this evening at ⁦@ASCO⁩ #GU26 ⁦@NimaSharifiMD⁩ ⁦@Daniel_J_George⁩ ⁦@dsui_miami_uro⁩ ⁦@SylvesterCancer⁩

@NimaSharifiMD @ASCO @SylvesterCancer @dsui_miami_uro Thank you! It became possible with your support 🙏

Congratulations @BitarafMasoudMD and all the other winners for your merit awards at the @ASCO GU symposium! @SylvesterCancer @dsui_miami_uro

CYP51A1: A Bypass Gateway for Androgen Synthesis, and a Potential Therapeutic Target for Resistant Prostate Cancer ⁦@BitarafMasoudMD⁩ ⁦@ASCO⁩ dailynews.ascopubs.org/do/cyp51a1-byp…

Should Capivasertib be added to SoC in PTEN deficient mHSPC? Promising data presented by @Daniel_J_George at @PCF_Science retreat @PCFnews

ONLINE NOW: Prostate cancer germline variants with therapeutic implications dlvr.it/TMD7yd

Working with two giants in the field of #prostatecancer has been incredibly fulfilling. @Ecastromarcos @NimaSharifiMD Read our review on germline variants with therapeutic implications👇🏻 @dsui_miami_uro @SylvesterCancer @PCFnews

I enjoyed working with @BitarafMasoudMD and @Ecastromarcos on this review on germline genetics in prostate cancer for @TrendsMolecMed! @dsui_miami_uro @SylvesterCancer @PCFnews

@Ecastromarcos @NimaSharifiMD It's been an honour to contribute alongside you

Germline variants with therapeutic implications in prostate cancer. It has been a pleasure to work with @BitarafMasoudMD and @NimaSharifiMD in this review focused on the role of HSD3B1 and BRCA2👇sciencedirect.com/science/articl…

@UMiamiHealth @dipenjparekh @univmiami Congratulations, Dr. @dipenjparekh

We’re proud to share that the University of Miami Board of Trustees has unanimously endorsed Dr. Dipen J. Parekh (@dipenjparekh) as the next Chief Executive Officer of UHealth and Executive Vice President for Health Affairs at the University of Miami (@univmiami). UHealth and the University of Miami Miller School of Medicine (@Umiamimedicine) are home to Sylvester Comprehensive Cancer Center (@sylvestercancer), the only NCI-designated cancer center in South Florida; Bascom Palmer Eye Institute (@bascompalmereye), the No. 1 eye hospital in the nation for 23 years; and the Desai Sethi Urology Institute (@dsui_miami_uro). Dr. Parekh is not only a visionary leader—he’s also a world-renowned surgeon, active researcher, and passionate educator. As Director of the Desai Sethi Urology Institute and former COO of UHealth, he’s been at the forefront of transforming patient care, research, and medical education. For the past five years, he’s worked alongside UHealth and Miller School of Medicine leadership to move our mission forward—and we’re just getting started. Please join us in celebrating this exciting new chapter for UHealth and our patients. 🙌 Learn more: loom.ly/1SOlSoM

Is #Viagra good for my #brain, too?! Read our meta-analysis on PDE5-inhibitors and #Alzheimers nature.com/articles/s4440… @Nature_NPJ @NaturePortfolio @SpringerNature @erfanamini @ParhamSalva Image: @edrugstoretv

@AkhKimiya :))

@AkhKimiya اینجوری نزدیک استوا همون بهشت موعود بود 😂

@ReihanLt میشه ساعتها توش زندگی کرد

گاهی باورم نمیشه این یه تصویر واقعی از یه کتابخونه نیست و خودم ساختمش:)

@AkhKimiya چقدر به همچین چیزی در پایان همچین روزی نیاز داشتم مثل همیشه همون نقل قولی که از شرلوک هولمز بت گفتم ❤️

@ParhamSalva Thanks Parham

@BitarafMasoudMD @NimaSharifiMD @univmiami @umiamimedicine @SylvesterCancer @dsui_miami_uro Good luck Masoud Jan.

Happy to join @NimaSharifiMD lab at @univmiami @umiamimedicine @SylvesterCancer as a post doctoral associate. Let's hope it'd be a fruitful collaboration with long-lasting impact on prostate cancer management. @dsui_miami_uro